comparing the baseline values across groups by gender, researchers found that male parkinson’s patients had lower weight, body mass index, percentage of red blood cells (also known as hematocrit), total and low-density cholesterol levels and serum creatinine levels. female patients had higher levels of blood pressure and an enzyme known as aspartate aminotransferase, while their other levels were lower than what they found in healthy female participants.
they then compared these levels over time in the parkinson’s patients who had yet not begun to experience motor issues and found increased blood pressure in women and decreased total and low-density cholesterol and hematocrit in men. it was the evidence they needed to prove it is possible to detect parkinson’s disease years earlier than medical knowledge currently allows.
“in this study, we found that blood pressure, hematocrit, and serum cholesterol levels are potential biomarkers of parkinson’s disease before the onset of its motor symptoms,” katsuno said. “this finding indicates that general health checkups can help detect early signs of developing parkinson’s disease.”
with more than 100,000 canadians living with parkinson’s today, and roughly 6,600 new diagnoses every year, it’s hard to overstate the benefits of early detection. typically diagnosed around the age of 65 when symptoms become undeniable, the associated costs of managing the incurable disease is more than $1.2 billion in canada. monthly medications alone cost the typical canadian patient more than $1,000 per month.
katsuno and his team are now studying the best way to identify people who present these biomarkers during annual exams and, hopefully, prevent them from ever experiencing a diagnosis. “we are conducting clinical trials of medication in the individuals who are considered, based on their checkup data, to be at high risk for parkinson’s, in an attempt to prevent the development of the disease in them.”